**Author details**

O.B.L. Alinde\* , A.J. Esterhuyse and O.O. Oguntibeju

\*Address all correspondence to: alindeb@cput.ac.za, lidwina785@gmail.com

Oxidative Stress Research Centre, Department of Biomedical Sciences, Faculty of Health & Wellness Sciences, Cape Peninsula University of Technology, Bellville, South Africa

[11] Odetola A, Akinloye O, Egunjobi C, Adekunle W, Ayoola A. Possible antidiabetic and antihyperlipidaemic effect of fermented *Parkia biglobosa* (jacq) extract in alloxan‐

Potential Role of *Parkia biglobosa* in the Management and Treatment of Cardiovascular Diseases

http://dx.doi.org/10.5772/57229

361

[12] Kassi Y, Aka KJ, Abo KJ, Mea A, Bi SAN, Ehile EE. Effet antihypertensif d' un extrait aqueux d' écorce de tronc de *Parkia biglobosa* (mimosaceae) sur la pression artérielle

[13] Kane MO, Sarr M, Gueye PM, Ndiaye CAB, Diaw M, Ba A, Sar FB, Sall/Diallo A. Ef‐ fets relaxants vasculaires d'un extrait hydroalcoolique d'écorce de *Parkia biglobosa*

[14] Olaleye TM, Komolafe K, Akindahunsi AA. Effects of methanolic leaf extract of *Par‐ kia biglobosa* on some biochemical indices and hemodynamic parameters in rats. J

[15] Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hyperten‐

[16] Olives C, Myerson R, Mokdad AH, Murray CJ, Lim SS. Prevalence, Awareness, Treatment, and Control of Hypertension in United States Counties, 2001–2009. PLoS

[17] Wilkins K, Campbell NR, Joffres MR, McAlister FA, Nichol M, Quach S, Johansen HL, Tremblay MS. Blood pressure in Canadian adults. Health Rep 2010; 21(1): 37-46.

[18] Atwood KM, Robitaille CJ, Reimer K, Dai S, Johansen HL, Smith MJ. Comparison of Diagnosed, Self-Reported, and Physically-Measured Hypertension in Canada. Can J

[19] Lu X, Shi P, Luo C, Zhou Y, Yu H, Guo C, Wu F. Prevalence of hypertension in over‐ weight and obese children from a large school-based population in Shanghai, China.

[20] Danielson M & Dammstrom B. The prevalence of secondary and curable hyperten‐

[21] Sinclair AM, Isles CG, Brown I, Cameron H, Murray GD, Robertson JW. Secondary hypertension in a blood pressure clinic. Arch Intern Med 1987; 147(7): 1289-1293.

[22] Anderson Jr GH, Blakeman N, Streeten DH. The effect of age on prevalence of secon‐ dary forms of hypertension in 4429 consecutively referred patients. J Hypertens 1994;

[23] Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T. Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a gener‐

al outpatient clinic in Japan. Hypertens Res 2004; 27(3): 193-202.

induced diabetic rats. Clin Exp Pharmacol Physiol 2006; 33(9): 808-812.

(mimosaceae). Science Lib Editions Mersenne 2009; 2 (090901).

de lapin. Sci. Nat 2008; 5(2): 133-143.

Chem Pharm Res 2013; 5(1): 213-220.

sion 2003; 42(6): 1206-1252.

One 2013; 8(4): e60308.

Cardiol 2013; 29: 606-612.

12(5): 609-615.

BMC Public Health 2013; 13(1): 24.

sion. Acta Med Scand Suppl 1981; 209(1‐6): 451-455.
